Brief: Sprint Bioscience Appoints Mathias Skalmstad As Acting CEO
Dec 28 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SPRINT BIOSCIENCE APPOINTS MATHIAS SKALMSTAD AS ACTING CEO
* BOD OF SPRINT BIOSCIENCE HAS TODAY APPOINTED CO'S CFO
MATHIAS
SKALMSTAD AS ACTING CEO AS OF JANUARY 23, 2023
* HE WILL TAKE OVER FROM CURRENT CEO ERIK KINNMAN
Source text for Eikon: ID:nMFN7fzdRY
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program